have attributed this loss of body fat, at least in part, to a circulatory lipid mobilising factor derived from the tumour cells . Although anorexia is common in cancer, loss of carcass fat cannot be attributed to a decreased caloric intake alone, since pair-fed rodents have been shown not to lose as much fat as tumour-bearing animals (Lundholm et al., 1981) . In some experimental models of cachexia, loss of host adipose tissue is associated with hyperlipidemia (Devereux et al., 1984) , although in the MAC16 model of cachexia, utilised in this study, plasma levels of both non esterified fatty acids (NEFA) and triacylglycerols have been shown to be reduced (Mahoney et al., 1988) , possibly due to an elevated level of lipoprotein lipase in skeletal muscle (Briddon et al., 1991) . This suggests that the liberated fatty acids are rapidly oxidised in this model. Changes in fuel utilisation have also been reported in cancer patients with lipid sources predominating (Warnold et al., 1978) .
In addition to host requirements the NEFA liberated during the cachectic process may also be required to maintain tumour growth. Nutritional conditions favouring mobilisation of host adipose tissue such as during an acute fast (Sauer & Dauchy, 1987a) and acute streptozotocin-induced diabetes (Sauer & Dauchy, 1987b) have been shown to stimulate tumour growth, suggesting that tumour growth in vivo may be limited by substances present in host fat stores. This view is strengthened by the observation that inhibition of host fat mobilisation in cancer cachexia is also associated with an inhibition of tumour growth . The present study documents changes of host lipid metabolism in a murine model of cachexia, the MAC16 colon adenocarcinoma. In comparison with other models this tumour induces profound weight loss in host animals with relatively small tumour burdens (>0.1% of host body weight) and without an alteration in food and water intake (Beck & Tisdale, 1987) (e.g. MAC 13), which can be utilised as a comparison to determine metabolic changes specific to the cachectic process.
Materials and methods
Pure strain NMRI mice bred in our own colony were fed a rat and mouse breeding diet (Pilsbury, Birmingham, UK) and water ad libitum. Fragments of either the MAC16 or MAC1 3 tumour were implanted into the flank of male NMRI mice (starting weight 24-26 g) by means of a trocar, as described (Bibby et al., 1987) . Animals sp.act. 114 mCi mmol ') (Amersham International, Amersham, Bucks, UK) together with 70 mg of non-labelled triolein was administered enterally by gastric intubation without anaesthesia to male NRMI mice bearing the MAC16 tumour and with weight loss, the MAC13 tumour or non tumourbearing controls, with minimal stress. Immediately after administration animals were placed in airtight metabolic cages and expired CO2 was collected for 5 h as described above. After 5 h, animals were anaesthetised and blood was collected by cardiac puncture. The complete gastrointestinal tract was removed and homogenised in 5 ml of 3% (w/v) HC104. Lipids were extracted from organs and blood by the method of Stansbie et al. (1976) . The extracted fatty acids were dissolved in Optiphase scintillation fluid and the radioactivity determined as above. Triolein absorption was calculated by subtracting the total gastrointestinal tract radioactivity from that administered.
Lipid mobilisation from direct injection of tracer into fat pads Serum was collected from male NRMI mice fed a 60% glucose: 40% rat and mouse breeding diet to lower their plasma NEFA level (Lyon et al., 1988) . [U-_4C]Palmitic acid (50 1.Ci sp.act. 828 mCi mmol ') was dissolved in 0.5 ml of 30% (w/v) KOH and the resultant soap was dried under nitrogen. The dried soap was dissolved in 2001l of 0.9% (w/v) NaCl and heated to 70°C until a clear solution was obtained. The soap solution was added dropwise to 200 pJ of the serum, the volume of the serum being minimised so that in the final complex, the molar ratio of NEFA to serum albumin was approximately 7:1 (Lyon et al., 1988) . A few drops of Evans Blue dye was added to the tracer to aid visual inspection after injection to mice. Animals were anaesthetised using a mixture of halothane, oxygen and nitrous oxide (halothane 2.5%, oxygen 0.5 ml min ', N2O 0.7 ml min '). A small incision was made in the lower abdomen and the left epididymal fat pad was gently externalised using a saline wetted probe. With the aid of the magnifying glass, 2 ptl of the tracer: albumin complex was injected into the fat pad using a Hamilton microsyringe. The fat pad was examined to ensure that no leakage of tracer had occurred. For time points beyond time zero the fat pad was gently returned to the abdominal cavity and the wound was clipped. At specified time points animals were sacrificed, tissues were removed and the concentration of labelled lipids determined by the methods of Stansbie et al. (1976) .
Oxidation ofpalmitate by tumour and host tissues Tissues were homogenised in 250 mM mannitol (500 mg tissue per ml) at 4°C and a portion of the homogenate corresponding to 100 mg of tissue was routinely incubated for up to 20 min at 37°C in a total volume of 2 ml containing 50 mm phosphate buffer, pH 7.4, 4 mM ATP, 95 mM KCI, 3 mM MgSO4, 0.1 mM sodium [U-"4C]palmitate (sp.act. 1 ttCi jtmole 1), 1 mM NAD, 40 mg albumin and 1 mg cytochrome C. The assay was terminated by the addition of 0.5 ml of 10% perchloric acid and the "4CO2 was trapped in centre wells containing 0.3 ml of 0.3 M NaOH. The water soluble products of palmitate oxidation were determined by extracting the radioactive lipid with four washes of petroleum and diethyl ether (95:2) (2 ml ml-' of incubation medium). Radioactivity was determined in Optiphase scintillation fluid as above.
Statistical analysis Differences between groups were determined by one way analysis of variance followed by Tukey's test.
Results
In order to minimise variations in the specific activity of blood glucose a bolus injection of D-[U-'4C]glucose was administered i.v. on a weight basis and production of "'CO2 was measured over a short time period (10 min). Using such a protocol, production of "'CO2 did not differ significantly between animals bearing either the MAC16 or MAC13 tumours and non tumour-bearing controls animals ( Figure   1 ).
The ability of the animals to deal with administered lipid was investigated using [1-"'C]triolein, which was given by intragastric intubation, and the absorption over a 5 h period was monitored (Table I) . While fat absorption in animals bearing the MAC16 tumour was not significantly different from that in non tumour-bearing controls, animals bearing the MAC13 tumour had a small, but significantly (P<0.05) reduced fat absorption over the 5 h period. This suggests that mobilisation of the host lipid stores in cancer cachexia (Beck & Tisdale, 1987; (0) In order to investigate utilisation of lipid by individual organs and tumour, the rates of oxidation of [U-'4C]palmitate to "'CO2 and water-soluble products was determined in homogenates. The rate of '4CO2 production was linear for a 20min period. The results presented in Table III show the major organ consuming palmitate was the liver. There was a 2-fold increase in conversion of [U-"'C]palmitate to "'CO2 in liver and heart of animals bearing the MAC16 tumour and a more than 2-fold increase in muscle from animals bearing both the MAC16 and MAC13 tumours. Respiration from palmitate was low in both tumours, but was significantly higher in the MAC16 than in the MAC13 tumour. Conversion of palmitate to water-soluble products was also significantly enhanced in hearts from MAC16 tumour-bearing animals when compared with either controls or MAC 13 tumour-bearing animals and was significantly enhanced in muscle of animals bearing both the MAC16 and MAC13 tumours. These results confirm that lipid oxidation was significantly higher in cachectic animals bearing the MAC16 tumour.
Discussion
In view of its high calorific value, fat is an important fuel source when the metabolic demands of an organism are high, and it appears to be the preferred calorie source in septic patients with and without cancer (Levinson et al., 1988) . We have previously reported that glucose utilisation by host organs, particularly the brain, is reduced in the tumour bearing state, to allow high glucose utilisation by the tumour (Mulligan & Tisdale, 1991a ) and the present results confirm that respiration from glucose is not elevated in animals bearing the MAC tumours. Brain metabolism was maintained by an increased utilisation of 3-hydroxybutyrate, which is derived from lipid metabolism in the liver. This suggests an increased lipid requirement in the tumour-bearing state. We have simulated the situation after a high fat meal by an oral load of triolein to cachectic and non-cachectic tumour-bearing animals to investigate alterations in the ability of the host to deal with administered lipid. Previous studies in rats (Evans & Williamson, 1988a,b; Argiles et al., 1989) have noted decreased lipid absorption and oxidation by two cytokines interleukin 1 and tumour necrosis factor alpha, while tumour burden (Walker 256 carcinoma) had no effect on lipid absorption and decreased oxidation. In the present study animals bearing the MAC13 tumour resembled more closely the effect of the cytokines with a slightly decreased lipid absorption compared with non tumour-bearing animals. In contrast animals bearing the MAC16 tumour and with weight loss between 2 and 4 g had a normal lipid absorption, but an increased oxidation of triolein compared with animals bearing the MAC 13 tumour or non tumour-bearing controls. This increased utilisation was reflected in a lowered accumulation of ['4C]lipid in heart and adipose tissue, and an increased oxidation of [U'4C]palmitate in fortified homogenates of liver, heart and skeletal muscle. Despite massive mobilisation of body fat reserves (Beck & Tisdale, 1987) animals bearing the MAC16 tumour do not exhibit hypertriglyceridemia, and we have recently attributed this to an increase in the level of lipoprotein lipase in both heart and adiopose tissue (Briddon et al., 1991) . Thus the tissues of cachectic animals have an increased utilisation of fat as an energy source, suggesting that the overall energy requirements are higher in the cachectic state. This increased requirement for lipid is shown not only by catabolism of adipose tissue, but also by an increased conversion of glucose to lipids (Mulligan & Tisdale, 1991b) and by an increased [14C]lipid accumulation by the MAC16 tumour. This suggests that fat may be able to overcome some of the metabolic defects seen in cancer cachexia. Animals studies using a rat model system have shown that hyperalimentation utilising fat as the primary source of calories generated a more favourable host: tumour balance, when measured by the relative rates of growth of each (Buzby et al., 1980) . Intravenous infusion of a commercial triglyceride emulsion to patients with malignant disease resulted in a decrease in calorie deficit and a gain in body weight, which correlated with a gain of intracellular material (Waterhouse & Nye, 1961) . Interestingly, the rate of removal of infused lipid from the blood was increased in patients with malignant disease paralleling the situation in the mouse model described in the present study.
The increased lipid oxidation in the cachectic state, together with the glucose requirement of the tumour, suggests an increased energy requirement, which could be met by an increased caloric intake. However, since the caloric intake in animals bearing the MAC16 tumour is not different from that found in non tumour-bearing controls, the increased metabolic demand would result in an energy deficiency leading to progressive weight loss.
